|
| References | Sample size (T/C) | Age (T/C) | Baseline difference | Treatment | Control | Treatment duration | Adverse effects report | Main outcomes |
|
| Ding and Lian 2015 [20] | 40/40 | / | NSD | BSHXP (1 dose/day) | Mifepristone (12.5 mg/d) | 6 months | Yes | Pregnancy rate, the serum level of CA125 |
| Zhou and Cong 2008 [21] | 30/30 | / | NSD | BSHXP (1 dose/day) | Diphereline (3.75 mg once monthly) | 6 months | Yes | Total effect rate, change in size of endometriotic cyst |
| Wei 2011 [22] | 50/50 | / | NSD | BSHXP (1 dose/day) | Gestrinone (2.5 mg/times, 2 times per week) | 3 months | No | Total effect rate |
| Shi et al. 2015 [23] | 30/30 | / | NSD | BSHXP (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 months | No | Total effect rate |
| Mei 2016 [24] | 30/20 | / | NSD | BSHXP (1 dose/day) | Mifepristone (12.5 mg/d) | 3 months | Yes | Total effect rate, change in size of endometriotic cyst, dysmenorrhea alleviation rate, the serum level of CA125 |
| Xu and Liu 2008 [25] | 52/51 | NR | NSD | BSHXP (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 months | No | Total effect rate |
| Xia and Qin 2008 [26] | 30/30 | NR | NSD | BSHXP (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 months | No | Total effect rate |
| Li 2005 [27] | 30/20 | / | NSD | BSHXP (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 months | No | Total effect rate, dysmenorrhea alleviation rate, change in size of endometriotic cyst |
| G.-M. Zhang and W.-Q. Zhang 2010 [28] | 20/20 | 31.5/32.3 | NSD | TKAB-basic formula (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 months | No | Total effect rate, the serum level of CA125 |
| Shen 2015 [29] | 30/20 | / | NSD | TKAB-basic formula | Mifepristone (10 mg/d) | 3 months | Yes | Total effect rate, dysmenorrhea alleviation rate, change in size of endometriotic cyst, the serum level of CA125 |
| Zhao 2008 [30] | 30/30 | / | NSD | BSHXP (1 dose/day) | Danazol (400 mg daily in 2 divided doses) | 3 month | Yes | Total effect rate, dysmenorrhea alleviation rate, change in size of endometriotic cyst |
| Jian et al. 1998 [31] | 58/45 | 33.6/33.8 | NSD | BSHXP (1 dose/day) | Danazol (600 mg daily in 3 divided doses) | 3 month | No | pregnancy rate, dysmenorrhea alleviation rate |
| Li and Yu 2007 [32] | 62/58 | NR | NSD | BSHXP (1 dose/day) | Mifepristone (12.5 mg/d) | 6 month | Yes | Total effect rate, dysmenorrhea alleviation rate, change in size of endometriotic cyst, pregnancy rate |
|
